Navigation Links
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
Date:3/19/2013

tances arising after the date hereof, except as may be required by law.

 

[Tables to Follow]

 Mast Therapeutics, Inc.(A Development Stage Enterprise)Condensed Consolidated Statements of Operations(In thousands except per share data)Three months ended
December 31,
(Unaudited)Year ended
December 31, (1)2012201120122011Total net revenue

$
8212;

$
8212;

$
8212;

$
8212;Operating expenses:Research and development

2,112

1,754

8,088

5,758Selling, general and administrative

1,787

1,810

7,519

7,190Transaction-related expenses

105

(1,130)

(69)

411Depreciation and amortization

12

9

90

38Total operating expenses

4,016

2,443

15,628

13,397Loss from operations

(4,016)

(2,443)

(15,628)

(13,397)Interest and other income, net

19

71

69

137Net loss

$
(3,997)

$
(2,372)

$
(15,559)

$
(13,260)Net loss per share – basic and diluted

$
(0.08)

$
(0.06)

$
(0.33)

$
(0.47)Weighted average shares – basic and diluted

47,419

37,091

47,641

28,175(1)

The condensed consolidated statements of operations for the years ended December 31, 2012 and 2011 have been derived from the audited financial statements but do not include all of the information and footnotes required by accounting principles generally accepted in the United States for the complete financial statements. Mast Therapeutics, Inc.(A Development Stage Enterprise)Balance Sheet Data(In thousands)December 31,2012December 31,2011Cash, cash equivalents and short-term investments

$
36,511$
50,704Working capital

34,60349,323T
'/>"/>

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Achieves ISO 13485 Certification
2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3. Echo Therapeutics Appoints Robert Doman to Board of Directors
4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
6. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
7. PTC Therapeutics Closes $60 Million Private Financing
8. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
9. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
10. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... personalized immune therapies for operable and inoperable solid tumor cancers, ... at the 7 th Annual Phacilitate Immunotherapy Forum in ... presentation at Phacilitate will take place on January 26 at ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... 7, 2007 - REGENERX,BIOPHARMACEUTICALS' (AMEX: RGN), www.regenerx.com ... the 2007 Association for Research in,Vision and ... May 9th to discuss TB4's ability to ... process closely,associated with inflammation that, if not ...
... TSX-V: PGA, VANCOUVER, May 07, 2007 /PRNewswire-FirstCall/ - ... results from its Phase I/II study of PAC-113, ... and active,in the treatment of oral Candida infection ... of care. Based on these results,the Company plans ...
Cached Medicine Technology:Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 2Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 3Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 2Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 3Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 4Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 5
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance ... reducing the costs of an auto insurance policy . , ... lower prices for their vehicle insurance policies. The safety a vehicle ... costs. Because of this, drivers should always carry a first ...
(Date:12/26/2014)... 2014 The US represents the largest market ... 2013, GlobalData’s forecast estimates that sales of branded therapies were ... to the high incidence of the disease, high drug treatment ... and China. Increased sales of CRC therapies over the forecast ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... 17 Clarent Hospital Corporation ... 12, 2007, the Company,s Board ... cash distribution to stockholders of ... is payable on October 31, ...
... 17 The Channel Islands,Alzheimer,s Institute recently received ... be received in four payments of $30,000,each beginning ... Institute is located on the campus of,California State ... donation are at least two student research,scholarships for ...
... Explanations and Insightful Tips for Finding ... Affordable Health Insurance for Your Family, SAN ... a leading source for online,health insurance quotes and ... library of consumer resources: the,Family Health Insurance Guide. Inspired ...
... Prudence Hall,founder of The Hall Center in Santa Monica, ... health of her patients. It wasn,t until she became,immersed ... started investigating her birth control patients more carefully.,"I was ... old patients on the,pill, had hormone levels that were ...
... establishing the Dyslexia Research Laboratory at Beth Israel Deaconess ... dramatic transformation in thinking among both scientists and the ... a host of explanations offered to explain dyslexia, says ... BIDMC whose work has played a key role in ...
... food is needed, study suggests , , WEDNESDAY, Oct. 17 ... to blame, research suggests. , Scientists from the University ... dopamine, a brain chemical that helps make eating and ... more food. , "We weren,t studying obesity, per se, ...
Cached Medicine News:Health News:Channel Islands Alzheimer's Institute Receives $120,000 Donation 2Health News:Health Insurance Finders Debuts A Comprehensive Guide to Family Health Insurance 2Health News:Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients 2Health News:Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients 3Health News:BIDMC Dyslexia Research Lab celebrates 25th anniversary 2Health News:Genes Might Help Drive Overeating 2Health News:Genes Might Help Drive Overeating 3
... is a safe, non-surgical process that ... tighten skin and reverse the signs ... dermis to cause collagen contraction while ... In addition, Titan can stimulate long-term ...
... The smallest, lightest, smartest choice , ... or neurological, ... environment. But will the device ... on its signal quality? Will the battery last? Is it comfortable, ...
... The modular AU5400 is a high-volume analyzer ... productivity of the AU5200 analyzer and the ... automates and consolidates chemistry-immuno testing with up ... to 6,600 tests per hour. Choose from ...
... the quantitative determination of Erythropoietin (EPO) in human ... diagnostic use, as an aid in the diagnosis ... the administration of recombinant erythropoietin as a biologic ... erythropoietin assay may be used also to aid ...
Medicine Products: